1-3 of 3
Daniel Murphy
Close
Sort by
Journal Articles

MYC-Alarmin Axis As a Novel Oncogenic Driver in a Subgroup of Triple Negative Myeloproliferative Neoplasms

Nicole D. Vincelette, Xiaoqing Yu, Andrew T. Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Hai Vu Nguyen, Erika Adriana Eksioglu, Onyee Chan, Najla H Al Ali, Parth C. Patel, Dae Hyun Lee, Shima Nakanishi, Renan Ferreira, Qianxing Mo, Suzanne Cory, Harshani Lawrence, Ling Zhang, Daniel Murphy, Rami S. Komrokji, Daesung Lee, Scott H. Kaufmann, John L. Cleveland, Seongseok Yun
Journal: Blood
Blood (2023) 142 (Supplement 1): 994.
https://doi.org/10.1182/blood-2023-174383
Published: 2023
Journal Articles

C-MYC Augments the Proliferation and Survival of Hematopoietic Stem Cells and Multipotent Progenitors to Drive Myeloproliferative Neoplasms

Nicole D. Vincelette, Jungwon Moon, Andrew T. Kuykendall, Ling Zhang, Rami S. Komrokji, Daniel Murphy, John L. Cleveland, Seongseok Yun
Journal: Blood
Blood (2021) 138 (Supplement 1): 28.
https://doi.org/10.1182/blood-2021-146399
Published: 2021
Journal Articles

Tfeb Links MYC Signaling to Epigenetic Control of Acute Myeloid Leukemia Cell Death and Differentiation

Seongseok Yun, MDPhD, Nicole D. Vincelette, PhD, Mario Fernandez, Xiaoqing Yu, PhD, Chunying Yang, Taro Hitosugi, PhD, Chia-Ho Cheng, PhD, Audrey Freischel, Ling Zhang, MD, Gregory Watson, PhD, Weimin Li, Hsin-An Hou, MD PhD, Franz Xaver Schaub, PhD, Alexis Vedder, BS, Ling Cen, PhD, Kathy McGraw, PhD, Daniel Murphy, PhD, Andrea Ballabio, Scott H. Kaufmann, MD PhD, Anders Berglund, John L. Cleveland, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137209
Published: 2020